Elo Mutual Pension Insurance Co Has $876,000 Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Elo Mutual Pension Insurance Co boosted its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 11.3% in the fourth quarter, HoldingsChannel.com reports. The firm owned 12,660 shares of the company’s stock after buying an additional 1,285 shares during the period. Elo Mutual Pension Insurance Co’s holdings in Henry Schein were worth $876,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Cerity Partners LLC raised its position in shares of Henry Schein by 12.3% during the third quarter. Cerity Partners LLC now owns 26,339 shares of the company’s stock worth $1,920,000 after acquiring an additional 2,894 shares during the last quarter. FMR LLC increased its position in Henry Schein by 7.8% during the 3rd quarter. FMR LLC now owns 3,280,890 shares of the company’s stock valued at $239,177,000 after purchasing an additional 237,888 shares during the period. BNP Paribas Financial Markets increased its position in Henry Schein by 5.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 184,482 shares of the company’s stock valued at $13,449,000 after purchasing an additional 9,465 shares during the period. Glenmede Trust Co. NA raised its holdings in Henry Schein by 13.3% during the 3rd quarter. Glenmede Trust Co. NA now owns 11,257 shares of the company’s stock worth $821,000 after purchasing an additional 1,324 shares during the last quarter. Finally, Public Sector Pension Investment Board lifted its position in shares of Henry Schein by 8.1% in the 3rd quarter. Public Sector Pension Investment Board now owns 5,336 shares of the company’s stock worth $389,000 after purchasing an additional 400 shares during the period. 96.62% of the stock is owned by institutional investors.

Henry Schein Stock Down 1.1 %

Shares of NASDAQ HSIC opened at $68.62 on Monday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a 50-day moving average price of $74.62 and a 200-day moving average price of $72.68. The stock has a market capitalization of $8.52 billion, a P/E ratio of 28.24, a P/E/G ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.49.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.66 EPS. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on HSIC shares. Mizuho assumed coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Jefferies Financial Group boosted their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Wells Fargo & Company began coverage on Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price for the company. Finally, UBS Group lowered their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Henry Schein currently has a consensus rating of “Moderate Buy” and an average price target of $81.10.

Insider Activity at Henry Schein

In other news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the business’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.